Search cutoffs
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Search companies, layoffs, filings, signals, and visa data
Current report (Form 8-K) · Jun 12, 2026 · Other material event · Financial statements
| Form type | Current report (Form 8-K) |
| Event summary | Other material event · Financial statements |
| Primary topic | Other material event |
| About this form | Public companies file this within four business days when something important happens that investors should know about, before the next quarterly report. |
| Why this was filed | Dianthus Therapeutics, Inc. /DE/ filed this to release information to investors under Regulation FD, usually a press release, conference presentation, or other event the company considers important. Advancing a leading autoimmune-focused company June 2026 Exhibit 99. 1 Forward-looking statements Certain statements in this presentation, other than purely historical information, may constitute “forward-looking statements” within the meaning of the federal securities laws, including for purposes of the safe harbor provisions under the United… |
| Labor angle | Watch for Item 2.05 (restructuring or severance), Item 5.02 (leadership changes), and Item 1.01 (major contracts that can precede workforce shifts). |
| Period of report | Jun 12, 2026 |
| Accession number | 0001690585-26-000029 |
| Reported items | Other events the company considers material, Financial statements and exhibits See Analysis tab for workforce implications |
